Anti-tumor activity of an antibiotic peptide derived from apoprotein E

In Vivo

Volumn 19, Issue 1, 2005, Pages 261-264

  Kojima, Taiki ^a   Fujimitsu, Yasunobu ^b   Kojima, Hiroshi ^b  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b AICHI PREFECTURAL UNIVERSITY   (Japan)

Author keywords

Anti tumor activity; Apoprotein E; Calcein leakage; Peptide

Indexed keywords

ANTINEOPLASTIC AGENT; APOLIPOPROTEIN E; CALCEIN; CHOLESTEROL; FLUOROURACIL; HEPARIN; LIPOSOME; POLYPEPTIDE ANTIBIOTIC AGENT; SODIUM CHLORIDE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL LINE; CHEMICAL COMPOSITION; COLON CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; DRUG MECHANISM; DRUG POTENTIATION; DRUG SYNTHESIS; HUMAN; HUMAN CELL; PANCREAS CANCER; STOMACH CANCER;

EID: 16244397135     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Azuma M, Kojima T, Del Carpio CA et al: A synthetic peptide of human apoprotein E with antibacterial activity. Peptides 21 327, 2000.
2. Clay MA, Anantharamaiah GM, Harmony JAK et al: Localization of a domain in apolipoprotein E with both cytostatic and cytotoxic activity. Biochemistry 34: 11142, 1995.
3. Hancock REW: Peptide antibiotics. Lancet 349: 418, 1997.
4. Westerhoff HV, Zasloff M, Rosner JL, Hendler RW, Juretic D, et al: Functional synergism of the magainins PGLa and magainin-2 in Escherichia coli, tumor cells and liposomes. Eur J Biochem 228 257, 1995.
5. Matsuzaki K, Sugishita K, Fujii N and Miyajima K: Molecular basis for membrane selectivity of an antimicrobial peptide, magainin 2. Biochemistry 34: 3423, 1995.
6. Ellrby HM, Arap W, Ellerby LM, Pasqualini R et al: Anti-cancer activity of targeted pro-apoptotic peptides. Nature Med 9 1032, 1999.
7. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application and cytotoxic assays. J Immunol Methods 65: 55, 1983.
8. Matuzaki K, Murase O, Tokuda H, Funakoshi S, Fujii N and Miyajima K: Orientation and aggregational states of magainin 2 in phospholopid bilayers. Biochemistry 33: 3342, 1994.
9. Vogar T, Guo N, Guly R, Krutzch HC, Robert DD et al: Apolipoprotein E: a potent inhibitor of endothelial and tumor cell proliferation. J Cell Biochem 54: 299, 1994.
10. Cardin AD and Weintraub HJR: Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis 9: 21, 1989.
11. Liu C, Balasubramaniam A, Saxon RE, Paiva M and MacFadden DW: Human pancreatic cancer growth is inhibited by peptide YY and BIM-43004-1. J Surg Res 58: 707, 1995.
12. Kling K, Kim F, Cole M and McFadden D: B-cell leukemia proteon-2 and peptide YY chemotherapy resistance in colon cancer. Am J Surg 178: 411, 1999.
13. Minakat H, Taylor, JW, Walker MW, Miller RJ and Kaiser ET: Characterization of amphiphilic secondary structure in neuropeptide Y through the design, synthesis and study of model peptides. J Biol Chem 264: 7907, 1989.
14. Vouldoukis I, Shai Y, Nicolas P and Mor A: Broad spectrum antibiotic activity of skin-PYY. FEBS Lett 380: 237, 1996.
15. Wakabayashi H, Matumoto H, Hayasawa H et al: N-acylated and D enantiomer derivatives of a nonamer core peptide of lactoferricin B showing improved antimicrobial activity. Antimicrobial Agents Chemother 43: 1267, 1999.